ESMO 2012 News

Welcome to ESMO 2012 news. Here you will find a selection of articles that appeared in the ESMO 2012 newspaper, Congress Daily, which was distributed to attendees of the ESMO congress in Vienna.

Complete copies of the four newspapers are available for download as PDF files

Filter

Date Title Topic
01 Oct 2012 New trial results on pazopanib have important implications for patients with advanced renal cell carcinoma Gastrointestinal cancers
01 Oct 2012 New weapons in the fight against cancer
01 Oct 2012 PHARE trial results comparing 6 to 12 months of adjuvant trastuzumab in early breast cancer Breast cancer
01 Oct 2012 PM01183: A promising new drug for ovarian cancer Genitourinary cancers
01 Oct 2012 Successes and failures: Do targeted therapies live up to their promise? Anticancer agents & Biologic therapy
30 Sep 2012 Dual therapy shows potential in melanoma Melanoma
30 Sep 2012 Analysis of NeoALTTO trial data: Too few women being offered breast-conserving treatment Breast cancer
30 Sep 2012 ARADES: A first-in-man study of ODM-201 Genitourinary cancers
30 Sep 2012 Case for including patients with brain metastases in clinical trials Head and neck cancers
30 Sep 2012 ESMO holds first session dedicated to Community Oncologists Anticancer agents & Biologic therapy
30 Sep 2012 EXPAND study shows no benefit from adding cetuximab to the first-line chemotherapy in advanced gastric cancer Gastrointestinal cancers
30 Sep 2012 Imaging biomarkers in the era of targeted therapies Imaging
30 Sep 2012 Joint ESMO-ESTRO symposium tackles brain metastases Head and neck cancers
30 Sep 2012 Let’s get personal about cancer Head and neck cancers
30 Sep 2012 Lurbinectedin shows activity in patients with platinum-resistant/refractory ovarian cancer Gynaecologic malignancies